Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq.

Al-Hussaniy, Hany A; Hassan, Alaa F; Oraibi, Amjad I; Al-Juhaishi, Atheer M R; Naji, Fatima A; Al-Tameemi, Zahraa S

Al-Hussaniy, Hany A; Hassan, Alaa F; Oraibi, Amjad I; Al-Juhaishi, Atheer M R; Naji, Fatima A; Al-Tameemi, Zahraa S.

Afiliación

Al-Hussaniy HA; Dr Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq.
Hassan AF; Department of Pharmacology, College of Medicine, University of Baghdad, Baghdad, Iraq.
Oraibi AI; Bilad Alrafidain University College, Baqubah, Iraq.
Al-Juhaishi AMR; Department of Pharmacy, Al-Mahmoudiya General Hospital, Baghdad, Iraq.
Naji FA; Department of Pharmacy, Al-Manara College for Medical Sciences, Amarah, Iraq.
Al-Tameemi ZS; Department of Clinical Pharmacy, College of Pharmacy/University of Karbala, Iraq.

J Pharm Bioallied Sci ; 15(3): 101-106, 2023.

Article en En | MEDLINE | ID: mdl-37705854

Palabras clave

Angiotensin receptor blocker; cytochrome P450 2C9; genetic polymorphism; renin-angiotensin-aldosterone system

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Pharm Bioallied Sci Año: 2023 Tipo del documento: Article País de afiliación: Irak Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google